Author Question: A client with herpes lesions on the face asks the nurse which medication has been prescribed. Which ... (Read 246 times)

kellyjaisingh · **on:** Jul 23, 2018

A client with herpes lesions on the face asks the nurse which medication has been prescribed. Which topical creams would be prescribed for this client?

1. Docosanol (Abreva)
2. Cidofovir (Vistide)
3. Famciclovir (Famvir)
4. Amantadine (Symmetrel)

Question 2

Zidovudine (Retrovir) has been prescribed to a client with HIV. The client asks why blood needs to be drawn on a regular basis. What is the most appropriate response by the nurse?

1. This medication can cause an increase in red and white blood cells, and needs to be monitored.
2. This medication can cause a secondary infection, so your blood needs to be monitored for this.
3. Serum creatinine must be monitored for clients taking zidovudine.
4. Reduced numbers of red and white blood cells are common, and need to be monitored.

milbourne11 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

1

Rationale 1: Docosanol (Abreva) is a topical cream.
Rationale 2: Cidofovir (Vistide) is an IV infusion for cytomegalovirus retinitis in clients with AIDS.
Rationale 3: Famciclovir (Famvir) is an oral medication and used for the treatment of HSV-2 and varicella-zoster.
Rationale 4:Amantadine (Symmetrel) is usedfor the treatment and prevention of influenza A and Parkinson disease.

Global Rationale: Docosanol (Abreva) is a topical cream. Cidofovir (Vistide) is an IV infusion for cytomegalovirus retinitis in clients with AIDS. Famciclovir (Famvir) is an oral medication and used for the treatment of HSV-2 and varicella-zoster. Amantadine (Symmetrel) is used for the treatment and prevention of influenza A and Parkinson disease.

Answer to Question 2

4

Rationale 1: This medication causes a decrease in red and white blood cells.
Rationale 2:This medication does not cause a secondary infection. The medication can decrease the white blood cells that fight infections.
Rationale 3: Serum creatinine does not need to be monitored with this medication.
Rationale 4: Zidovudine can result in severe toxicity to blood cells at high doses. Reduced numbers of red blood cells (anemia) and white blood cells (leukopenia) are common, and can limit therapy.

Global Rationale: Zidovudine can result in severe toxicity to blood cells at high doses. Reduced numbers of red blood cells (anemia) and white blood cells (leukopenia) are common, and can limit therapy.